Collaborative Trial of Fluvastatin on Atrial Fibrillation

UMIN ID: UMIN000000582

Registered date:31/01/2007

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: paroxysmal atrial fibrillation or transient atrial fibrillation
• Date of first enrollment: 2007/02/01
• Target sample size: 300
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

fluvastatin add-on therapy
conventional therapy

Outcome(s)

• Primary Outcome: 1) maintenance of sinus rhythm 2) frequency of atrial fibrillation occurrence
• Secondary Outcome: 1) new onset or recurrence of brain attack (including TIA) 2) hospitalization due to heart failure 3) other cardiovascular events 4) other adverse events

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: 1) patients who underwent catheter ablation within 3 months 2) patients who underwent cardiac surgery within 1 month 3) patients with a history of cerebrovascular disorder or myocardial infarction within 1 month 4) patients with severe heart failure 5) patients with dialysis or severe renal dysfunction 6) patients with severe liver dysfunction 7) other patients who are judged to be inappropriate for the study by the investigator

Related Information

• Primary Sponsor: CO-FAT study group